CPHI Webinar Series

Develop ODTs in a FLASH with UltraBurst™

September 22nd, 2021
4pm CET / 10am EST
What will this webinar address?

In this webinar aimed at Formulators, R&D Managers, and Product Marketing Executives, we will explain the challenges associated with development of Orally Disintegrating Tablets. UltraBurst, the first in class excipient platform for flash ODTs, will be introduced and discussed. We also will show how, by combining UltraBurst technology with our in-house formulation development capabilities, we can support customers to design superior flash and conventional ODT systems that have exceptional functionality.

When you attend this webinar, you will:
  • Hear experts discuss solutions to challenging ODT formulations
  • Gain an understanding of a new, preformulated product for flash disintegration
  • Have an opportunity for live Q&A with the ODT experts
Dr. Graeme Macleod
Global Research & Development Manager
SPI Pharma

Graeme is a pharmacist and attained his PhD in Pharmaceutical Technology from the University of Manchester, England. His 25 years of industrial experience were gained in a number of positions within Industry in the fields of formulation development and drug delivery and Senior Technical Positions within Pharmaceutical Solid Form equipment and excipient companies. Graeme joined SPI Pharma in June 2017. His areas of experience include oral dose form technologies and processes, novel soft capsule technologies, and drug formulation.

Dr. Geetha Thanga Mariappan
Group Lead- Formulation
SPI Pharma

Dr. Geetha Thanga Mariappan has over 16 years of research and development of formulation experience. Her broad formulation experience includes Solid oral dosage development for NCE, ANDA, 505(b)2, Semisolid dosage forms and NDDS. Geetha has published 15 research articles in various global publications, a book chapter, two patents and holds a Ph. D from Punjab University and a M.S. (Pharm.) in Pharmaceutics from NIPER, Mohali, India. Prior to joining SPI Pharma, she held a variety of research and formulation development roles at Syngene International Ltd., Genovo Development Services (Medreich) and Piramal Healthcare Ltd, India.

This webinar is brought to you by

Develop ODTs in a FLASH with UltraBurst™
  • September 22nd, 2021
  • 4pm CET / 10am EST
  • 60 minutes
  • Free
CPHI Newsletter

Get the latest from CPHI in your inbox every week.

You understand that your information will be used in accordance with our Privacy Policy, and that you may withdraw your permission to receive any of our communications at any time by clicking on the Unsubscribe link in the Newsletters or opting out on our unsubscribe page page.